TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Avansor Pharma Oy
Closing information (x1000 DKK)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
14,728
|
9,567
|
11,793 |
| Financial expenses |
67
|
37
|
7 |
| Earnings before taxes |
5,791
|
3,142
|
2,777 |
| Total assets |
29,002
|
25,170
|
21,501 |
| Current assets |
13,293
|
4,336
|
6,120 |
| Current liabilities |
4,096
|
2,582
|
1,988 |
| Equity capital |
22,675
|
20,357
|
19,514 |
| - share capital |
238
|
239
|
238 |
| Employees (average) | 3 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
78.2%
|
80.9%
|
90.8% |
| Turnover per employee | 3,931 | ||
| Profit as a percentage of turnover |
39.3%
|
32.8%
|
23.5% |
| Return on assets (ROA) |
20.2%
|
12.6%
|
12.9% |
| Current ratio |
324.5%
|
167.9%
|
307.8% |
| Return on equity (ROE) |
25.5%
|
15.4%
|
14.2% |
| Change turnover |
5,197
|
-2,254 | |
| Change turnover % |
55%
|
-19% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.